Back
Voyager Therapeutics Quote, Financials, Valuation and Earnings

Claim $10,000 in FREE Silver in 2023
Click Here to get all of the details in this FREE Kit!
Sell
48
VYGR
Voyager Therapeutics
Last Price:
12.71
Seasonality Move:
-7.16%
7 Day Trial
ALL ACCESS PASS
$
7

Stop Trading Like a Turtle.
Click Here to Attend Our Next Free Live A.I. Market TrainingVoyager Therapeutics Price Quote
$12.71
-0.08 (0.71%)
(Updated: June 9, 2023 at 5:42 AM ET)
Voyager Therapeutics Key Stats
Sell
48
Voyager Therapeutics (VYGR)
is a Sell
Day range:
$12.66 - $13.18
52-week range:
$4.61 - $14.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.66
P/B ratio:
2.57%
Volume:
744.4K
Avg. volume:
740.4K
1-year change:
126.37%
Market cap:
$556.8M
Revenue:
$40.9M
EPS:
$2.28
How Much Does Voyager Therapeutics Make?
-
How Much Are Voyager Therapeutics's Sales Annually?
VYGR Revenues are $40.9M -
How Much Profit Does Voyager Therapeutics's Make A Year?
VYGR net income is -$46.4M
Is Voyager Therapeutics Growing As A Company?
-
What Is Voyager Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 227.69% -
What Is Voyager Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Voyager Therapeutics Stock Price Performance
-
Did Voyager Therapeutics Stock Go Up Last Month?
Voyager Therapeutics share price went up by 53.91% last month -
Did VYGR's Share Price Rise Over The Last Year?
VYGR share price rose by 126.37% over the past 1 year
What Is Voyager Therapeutics 52-Week High & Low?
-
What Is Voyager Therapeutics’s 52-Week High Share Price?
Voyager Therapeutics has traded as high as $14.34 over the past 52 weeks -
What Is Voyager Therapeutics’s 52-Week Low Share Price?
Voyager Therapeutics has traded as low as $4.61 over the past 52 weeks
Voyager Therapeutics Price To Free Cash Flow
-
Is Voyager Therapeutics Stock Overvalued?
Voyager Therapeutics is trading at a price to free cash flow ratio of 6.88 -
Is Voyager Therapeutics Stock Undervalued?
Voyager Therapeutics EV to Free Cash Flow ratio is 3.85 -
What Is Voyager Therapeutics’s Price Earnings Growth Ratio?
VYGR PEG ratio is 0.00 -
Is Voyager Therapeutics Trading At A Premium To Earnings?
Voyager Therapeutics EV to EBIT ratio is 3.04
Is It Risky To Buy Voyager Therapeutics?
-
How Much Debt Does Voyager Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Voyager Therapeutics Have?
Cash and short term investments quarterly total is $273.3M -
What Is Voyager Therapeutics’s Book Value Per Share?
Book value per share is 5.00
Is Voyager Therapeutics Cash Flow Positive?
-
What Is VYGR Cash Flow From Operations?
Cash flow from operations (TTM) is $76.6M -
What Is Voyager Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $32.4M -
What Is Voyager Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $27.2M
Voyager Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
VYGR return on invested capital is 100.61% -
What Is Voyager Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is 45.35% -
What Is VYGR Return On Equity?
ROE is a measure of profitability and is 100.61%
Voyager Therapeutics Earnings Date & Stock Price
-
What Is Voyager Therapeutics's Stock Price Today?
A single share of VYGR can be purchased today for 12.79 -
What Is Voyager Therapeutics’s Stock Symbol?
Voyager Therapeutics trades on the nasdaq under the ticker symbol: VYGR -
When Is Voyager Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Voyager Therapeutics is scheduled on August 4, 2023 -
When Is VYGR's next ex-dividend date?
Voyager Therapeutics's next ex-dividend date is June 9, 2023 -
How To Buy Voyager Therapeutics Stock?
You can buy Voyager Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Voyager Therapeutics Competitors
-
Who Are Voyager Therapeutics's Competitors?
Below is a list of companies who compete with Voyager Therapeutics or are related in some way:
Voyager Therapeutics Dividend Yield
Data Unavailable
Voyager Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 133.8% |
Revenue: | 22769.3% | 186.63% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 12.57 |
Downside from Last Price: | -1.71% |